Акции фармацевтической компании Beximco Pharmaceuticals достигли нового годового максимума

Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 62.50 and last traded at GBX 60.75, with a volume of 53833 shares trading hands. The stock had previously closed at GBX 55. Beximco Pharmaceuticals Price Performance The stock has a 50-day moving average price of GBX 52.85 and a 200 day moving average price of GBX 46.15. The company has a debt-to-equity ratio of 5.27, a current ratio of 4.13 and a quick ratio of 0.37. The firm has a market cap of £272.13 million, a price-to-earnings ratio of 0.03 and a beta of 0.25. Beximco Pharmaceuticals Company Profile Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines. Featured Articles Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.